Osiris Therapeutics Inc.
Shares rose $1.29 to $13.86 after the Columbia-based company said the U.S. government will pay it up to $224.7 million to develop and stockpile its stem cell treatment for radiation exposure.
Stock of interest
The Baltimore Sun
Copyright
© 2021, The Baltimore Sun, a Baltimore Sun Media Group publication | Place an Ad